InvestorsKeyhole Insider Activity

Esperion CEO Buys 5,000 Shares

Timothy Mayleben, the president and CEO of Esperion Therapeurics Inc. (ESPR), bought 5,000 shares of the company’s common stock on March 29. At $40.00 per share, Mayleben paid a total of $200,000 for the new shares.

Already a member?

Login to see your Insider Activity Trade Idea.

Not yet a member?

You can receive four timely bull-put credit spreads each market day by joining our InvestorsKeyhole Daily Trade Alerts Service. Our analysts scour the news looking for unusual options activity, how insiders are trading, and breaking news, and publish trades accordingly.

Become A Member

ESPR
About Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm has Business of researching, developing and commercializing therapies for the treatment of patients with the elevated LDL-C operating segment.

Download this step-by-step guide on placing InvestorsKeyhole Daily Trade Alerts.

How to place a credit spread

How to place a vertical debit spread

|

You May Also Like